With specialty companies getting smarter in applying their big data insights to product marketing, the true commercial potential of machine learning and predictive modeling may soon be within reach As we advance to an age where almost every new drug entering the market will be a specialty drug, the word “specialty” itself may eventually become redundant.

With specialty companies getting smarter in applying their big data insights to product marketing, the true commercial potential of machine learning and predictive modeling may soon be within reach As we advance to an age where almost every new drug entering the market will be a specialty drug, the word “specialty” itself may eventually become redundant.

Source: pharmexec.com
Author: Julian Upton